ClinicalTrials.govpublic full text
Anti-CD19 CAR-T Cell Therapy for Patients With Refractory Systemic Lupus Erythematosus
system lupus erythematosus(sle), academic car-t cell product refractory, refractory sle, efficacy, safety, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 813961
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.